Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lillicrap

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand diseaseM Bowman, G Mundell, J Grabell, et al.
British Journal of Haematology|August 1, 1995
Severe haemophilia A in a female resulting from two de novo factor VIII mutationsS Windsor, A Lyng, S A Taylor, et al.
Journal of Thrombosis and Haemostasis : JTH|August 7, 2016
Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTHA Iorio, A M Barbara, F Bernardi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 16, 2008
A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucroseM Rubinger, D Lillicrap, G E Rivard, et al.
Journal of Thrombosis and Haemostasis : JTH|July 11, 2006
Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domainF E Rawle, K P Pratt, A Labelle, et al.
Journal of Thrombosis and Haemostasis : JTH|February 17, 2016
Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTHM Othman, H Kaur, E J Favaloro, et al.
Integrated Environmental Assessment and Management|January 20, 2022
Weight of evidence tools in the prediction of acute fish toxicityScott E Belanger, Adam D Lillicrap, S Jannicke Moe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 22, 2009
In vitro and in vivo stability of diluted recombinant factor VIII for continuous infusion use in haemophilia AS Revel-Vilk, V S Blanchette, M Schmugge, et al.
Thrombosis and Haemostasis|March 11, 1998
The canine factor VIII cDNA and 5' flanking sequenceC Cameron, C Notley, S Hoyle, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2007
Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort studyP D James, C Notley, C Hegadorn, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand diseaseM Bowman, G Mundell, J Grabell, et al.
British Journal of Haematology|August 1, 1995
Severe haemophilia A in a female resulting from two de novo factor VIII mutationsS Windsor, A Lyng, S A Taylor, et al.
Journal of Thrombosis and Haemostasis : JTH|August 7, 2016
Recommendations for authors of manuscripts reporting inhibitor cases developed in previously treated patients with hemophilia: communication from the SSC of the ISTHA Iorio, A M Barbara, F Bernardi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 16, 2008
A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucroseM Rubinger, D Lillicrap, G E Rivard, et al.
Journal of Thrombosis and Haemostasis : JTH|July 11, 2006
Induction of partial immune tolerance to factor VIII through prior mucosal exposure to the factor VIII C2 domainF E Rawle, K P Pratt, A Labelle, et al.
Journal of Thrombosis and Haemostasis : JTH|February 17, 2016
Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTHM Othman, H Kaur, E J Favaloro, et al.
Integrated Environmental Assessment and Management|January 20, 2022
Weight of evidence tools in the prediction of acute fish toxicityScott E Belanger, Adam D Lillicrap, S Jannicke Moe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 22, 2009
In vitro and in vivo stability of diluted recombinant factor VIII for continuous infusion use in haemophilia AS Revel-Vilk, V S Blanchette, M Schmugge, et al.
Thrombosis and Haemostasis|March 11, 1998
The canine factor VIII cDNA and 5' flanking sequenceC Cameron, C Notley, S Hoyle, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2007
Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort studyP D James, C Notley, C Hegadorn, et al.
Pageof 14